Antimicrobial peptides including bee venom-derived Melittin and insect-derived Cecropin A effectively killed colorectal cancer cells in 3D tumor models and triggered cell cycle arrest.
Melittin and hybrid most effectiveAmong three antimicrobial peptides tested, Melittin and the Cecropin A-Melittin hybrid showed the greatest anticancer activity against 3D colorectal cancer spheroids
What the researchers found
Three antimicrobial peptides — Melittin, Cecropin A, and a Cecropin A-Melittin hybrid — were tested against 3D colorectal cancer spheroids. All three peptides reduced cell viability and compromised spheroid structure. Melittin and the hybrid peptide were the most effective, showing greater anticancer activity than Cecropin A alone. The peptides increased ATP and LDH release (indicators of membrane damage and cell death), arrested cancer cells in the G2/M phase of the cell cycle, and increased the number of senescent (non-dividing) cells.
Why it matters
Colorectal cancer is the third most common cancer worldwide and often develops resistance to conventional chemotherapy. Antimicrobial peptides like Melittin and Cecropin A can selectively target cancer cells through membrane disruption mechanisms that are harder for tumors to develop resistance against, offering a potential alternative or complement to standard treatments.
The numbers in context
3 peptides tested · 2 colorectal cancer spheroid models · cell viability reduced · ATP and LDH elevated · G2/M cell cycle arrest · increased cellular senescence · Melittin and hybrid most effective
How the study worked
In vitro study using two human colorectal cancer cell line-derived 3D spheroids (a more realistic model than flat cell cultures). Cell viability was measured using MTT, LDH, and ATP assays at different peptide concentrations. Cell cycle analysis and cellular senescence assays were performed to understand mechanisms of action.
Who was studied
Two human colorectal cancer-derived 3D spheroid cell cultures (in vitro laboratory study)
What this study cannot tell us
In vitro study using 3D spheroids but no in vivo animal testing. Melittin is known to have toxicity to normal cells (it is bee venom peptide), and the study does not provide detailed selectivity data comparing cancer vs normal cell effects. Specific concentrations and dose-response curves are not detailed in the abstract.
How to read the evidence
In vitro laboratory study using 3D spheroid models, which are more physiologically relevant than 2D cultures but still far from clinical evidence. No in vivo testing was performed. Multiple assays (MTT, LDH, ATP, cell cycle, senescence) provide comprehensive mechanistic data.
When this study was published
Published in 2023, this study contributes to the growing field of anticancer antimicrobial peptides, using modern 3D culture techniques that better predict in vivo behavior.
The bigger picture
Cancer cells can develop resistance to conventional chemotherapy by changing their internal drug targets, but antimicrobial peptides attack the cell membrane — a target that is much harder to alter through resistance mutations. Using 3D spheroid models (more predictive than traditional flat cultures) strengthens these findings and moves the field closer to potential clinical translation of anticancer peptides.
Questions still open
- Can the Cecropin A-Melittin hybrid be optimized to maximize cancer killing while minimizing toxicity to normal cells?
- Would these peptides show anticancer effects in animal models of colorectal cancer?
- Could these antimicrobial peptides be combined with standard chemotherapy to overcome drug resistance?
Common questions
Why test antimicrobial peptides against cancer?
What is Melittin and is bee venom safe for cancer treatment?
Read the original research
Cancer Wars: Revenge of the AMPs (Antimicrobial Peptides), a New Strategy against Colorectal Cancer.
Toxins, 15(7)
Citation
Răileanu, Mina; Bacalum, Mihaela. (2023). Cancer Wars: Revenge of the AMPs (Antimicrobial Peptides), a New Strategy against Colorectal Cancer.. Toxins, 15(7). https://doi.org/10.3390/toxins15070459